Medical technology

ALTERNATIVE LABELS
Medical innovations


Report

The roadmap to telehealth efficacy: care, health, and digital equities

In this paper, the authors propose flexibilities within the current health care system that accommodate the changes imposed by new technologies, as well as continued government incentives to drive more competitive options and alternatives for health care delivery.
Audio podcast

Research that matters: building health solutions

From vaccines to antibiotics, health and medical research has improved, extended, and saved lives. In this episode, Torrens University researchers talk about the need to build a new GP model of care for Australia’s rapidly ageing population.
Journal article

Changes in US hearing aid regulations: possible benefits and risks to Australia

This paper predicts that the hearing health system in Australia will undergo tremendous change in the coming years because of the introduction of over-the-counter hearing aids in the US.
Report

The new frontier - delivering better health for all Australians

This report examines the opportunities to deliver better health care for Australians through our regulatory and health technology assessment process for both medicines and technologies.
Report

Funding rare disease therapies in Australia: 2021 progress update

For the 2 million Australians living with rare diseases, access to medicines can be inadequate. This report reassesses 2014 research by the McKell Institute, assessing the state of rare disease therapies in Australia.
Report

Diabetes technology in Australia: scoping report

The availability and access of technology for managing diabetes has changed. This scoping report describes the current data gaps and currently available data sources for monitoring the use of technology (devices) for the management of diabetes. The report also briefly outlines the approval, access and...
Report

Department of Health’s management of financial assistance under the Medical Research Future Fund

The objective of this audit was to assess whether the Department of Health is effectively managing financial assistance under the Medical Research Future Fund.
Strategy

Australian Medical Association's vision for Australia's health

This strategy document represents a clear blueprint for all governments and players in Australia's health system, and is built around five pillars of detailed policy reform.
Report

Securing a positive health care technology legacy from COVID-19

This report explores the challenges of implementing health care technologies and investigates patient and staff experiences of technology during the first phase of the coronavirus pandemic. It draws on learning from the Health Foundation’s programmes and YouGov surveys of over 4,000 UK adults and over...
Journal article

An empirical meta-analysis of the life sciences linked open data on the web

In this paper, the authors extract schemas from more than 80 biomedical linked open data sources into an Life Sciences Linked Open Data (LSLOD) schema graph and conduct an empirical meta-analysis to evaluate the extent of semantic heterogeneity across the LSLOD cloud.
Report

Testing for COVID-19: the current state of laboratory tests and recommendations within the context of New Zealand’s pandemic response

The purpose of this document is to provide a rapid point-in-time evaluation of the different testing strategies for COVID-19 and recommend some possible options, scenarios and tests that may benefit New Zealand’s pandemic response. Relevant to this document, is that COVID-19 testing is a rapidly...
Report

Global Innovation Index 2019

The Global Innovation Index (GII) is a source of insight into the multidimensional facets of innovation-driven growth. In this year’s edition, it analyzes the medical innovation landscape of the next decade, looking at how technological and non-technological medical innovation will transform the delivery of healthcare...
Discussion paper

Mitochondrial donation: issues paper

This paper provides an overview of mitochondrial donation and related ethical and social issues in the context of Australian law. The purpose of this paper is to inform and engage the Australian community and to seek views on the issues raised.
Report

Gene editing: legal and regulatory implications

This report by the Royal Society Gene Editing Panel examines New Zealand's current legal and regulatory environment for genetic technology in Aotearoa.
Report

The core information standard

The report defines the digital health information that should be shared, by consulting widely with people who use services, health and care professionals. The consultation was conducted across the four nations, because the information needed to provide safe, high quality care should follow the person...
Report

The Nightingale: time to get serious about addressing the social, behavioural and environmental influences on health

This paper proposes a new centre of innovation and research excellence to equip Nesta with the knowledge necessary to improve the social, behavioural and environmental determinants of health.
Briefing paper

Promoting an overdue digital transformation in healthcare

Following an analysis of a dozen countries with digitally advanced health economies, this paper aims to deconstruct and distill a set of six conditions that can smooth the path toward a successful systemwide digital transformation in healthcare.
Report

Shaping the future of UK healthcare: closing the digital gap

The latest report from from Deloitte's Centre for Health Solutions, examines the current challenges facing the healthcare system in realising the policy ambition of a digital first NHS, and some of the solutions to overcome them.
Article

Time to make a fundamental choice about the future of healthcare

Smart, mobile, connected technologies are the potential saviors of healthcare systems worldwide. The only possible solution to the global challenge of healthy ageing is to exploit the connectivity of our consumer devices as diagnostic and monitoring tools.
Report

A vision for Medical Affairs in 2025

Medical Affairs—a third strategic pillar for the pharmaceutical enterprise